In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three vaccines available in the U.S.

Summer's rise in COVID-19 cases led to the approval of updated versions of vaccinations targeting recent strains for the 2024 ...

Moderna is trying to find a path to profitability in the wake of disappointing vaccine sales. In September, the company said ...

The Ministry of Health has approved Moderna's updated COVID vaccines, which target the new JN1 variant of the virus.

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

Half will receive the vaccine while the rest have a placebo saline injection. If the jab is shown to be effective at ...

In other parts of the world, Moderna's vaccine shares the ... times higher in people who received the J&J vaccine compared to the Pfizer-BioNTech injection. The J&J vaccine is a single-dose ...

The first, an investigational norovirus mRNA vaccine from Moderna (mRNA-1403), safely elicited strong antibody responses in ...

There are three different COVID vaccines to choose from this season: two mRNA vaccines from Pfizer and Moderna ... redness or swelling at the injection site Serious adverse reactions are even ...

For the Pfizer/BioNTech and Moderna vaccines, this means that small changes ... swelling and redness at the injection site; tiredness; headache; muscle pain; chills; and fever.

The Centers for Disease Control recommends staying up to date on COVID-19 vaccinations, especially individuals 65 years and older and those more vulnerable to the virus due to weakened immune systems.